Pfizer seeks FDA clearance for COVID-19 vaccine in younger children


Reuters | Updated: 28-09-2021 16:48 IST | Created: 28-09-2021 16:20 IST
Pfizer seeks FDA clearance for COVID-19 vaccine in younger children

Pfizer Inc and BioNTech SE on Tuesday asked U.S. health regulators to authorize their COVID-19 vaccine in kids aged 5 to 11.

The application to the U.S. Food and Drug Administration comes as COVID-19 infections have soared in children, hitting their highest point in early September, according to data from the American Academy of Pediatrics.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Give Feedback